Abstract
89Zr is an emerging radionuclide with promising application in nuclear medicine for the non-invasive diagnosis of various cancers with PET imaging. This paper would discuss optimization efforts in the production of 89Zr carried out at Accelerator Radioisotope Development Team, Korea Atomic Energy Research Institute. Optimized conditions reveal high production yields of 89Zr ~ 37 ± 1.4 MBq/µA using 89Y(p,n)89Zr, ~ 12.7 MeV of proton, and 35 µA using yttrium coin target with indigenously constructed 30 MeV Cyclotron (RFT-30). Besides, the production optimization, quality control, and biological behavior of [89Zr]Zr-oxalate, chloride and, DFO demonstrated promising results.
Similar content being viewed by others
References
Khater S, El–Sharawy DM, El Refaye MS, Farrag NS Optimization and tissue distribution of [125I] iododomperidone as a radiotracer for D
Kiko T, Yoshihisa A, Yokokawa T, Misaka T, Yamada S, Kaneshiro T, Nakazato K, Takeishi Y (2020) Direct comparisons of left ventricular volume and function by simultaneous cardiac magnetic resonance imaging and gated ammonia positron emission tomography. Nucl Med Commun 41(4):383–388
Mapelli P, Incerti E, Ceci F, Castellucci P, Fanti S, Picchio M (2016) 11 C-or 18F-choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer. J Nucl Med 57(Suppl 3):43S–48S
Datta-Mannan A (2019) Mechanisms influencing the pharmacokinetics and disposition of monoclonal antibodies and peptides. Drug Metab Dispos 47(10):1100–1110
Fischer G, Seibold U, Schirrmacher R, Wängler B, Wängler C (2013) 89Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges. Molecules 18(6):6469–6490
Ryman JT, Meibohm B (2017) Pharmacokinetics of monoclonal antibodies. CPT Pharm Syst Pharmacol 6(9):576–588
Sitarz M (2019) Research on production of new medical radioisotopes with cyclotron. warsaw university; université de Nantes
Tian J, Wu H, Hao H, Liu G, Luo H, Wang X Temperature and optimize design of beam window in the accelerator driven sub-critical system
Leonte R, Cocioabă D, Chilug L, Băruță S, Eșanu T, Burghelea B, Chiriacescu A, Crăciun L, Niculae D (2020) Process validation for production of copper radioisotopes in a TR-19 variable energy cyclotron. In: AIP conference proceedings. AIP Publishing LLC, p 020022
MacDONALD NS (1975) Cyclotron-produced radionuclides. In: Radiopharmaceuticals
Sajjad M, Lambrecht RM (1989) Cyclotron targetry for medical radioisotope production. Nucl Instrum Methods Phys Res Sect B 40:1100–1104
Uddin M, Hagiwara M, Baba M, Tarkanyi F, Ditroi F (2005) Experimental studies on excitation functions of the proton-induced activation reactions on yttrium. Appl Radiat Isot 63(3):367–374
Kandil S, Spahn I, Scholten B, Saleh Z, Saad S, Coenen H, Qaim S (2007) Excitation functions of (α, xn) reactions on natRb and natSr from threshold up to 26 MeV: possibility of production of 87Y, 88Y and 89Zr. Appl Radiat Isot 65(5):561–568
Manenti S, Haddad F, Groppi F (2019) New excitation functions measurement of nuclear reactions induced by deuteron beams on yttrium with particular reference to the production of 89Zr: nuclear instruments and methods. Phys Res Sect B Beam Interact Mater Atoms 458:57–60
Omara H, Hassan K, Kandil S, Hegazy F, Saleh Z (2009) Proton induced reactions on 89Y with particular reference to the production of the medically interesting radionuclide 89Zr. Radiochim Acta 97(9):467–471
Pavlik A, Winkler G, Vonach H, Paulsen A, Liskien H (1982) Precise measurement of cross sections for the 90Zr (n, 2n) 89Zr reaction from threshold to 20 MeV. J Phys G Nucl Phys 8(9):1283
Jason PH, Yiauchung S, Jason SL (2009) Standardized methods for the production of high specific-activity zirconium-89. J Nucl Med Biol 36:729–739
Marchand B, Prieels D, Bauvir B, Sépulchre R, Gérard M IBA proton pencil beam scanning: an innovative solution for cancer treatment. In: Proceedings of EPAC (2000) pp 2539–2541
Lee JY, Vyas CK, Kim GG, Choi PS, Hur MG, Yang SD, Kong YB, Lee EJ, Park JH (2019) Red blood cell membrane bioengineered Zr-89 labelled hollow mesoporous silica nanosphere for overcoming phagocytosis. Sci Rep 9(1):1–9
Acknowledgements
This researchwas supported by the Nuclear R&D Program through the National Research Foundation of Korea, funded by the Ministry of Science, ICT, and Future Planning (2017M2A2A6A05016600 and 2021M2E7A1079112) and NTIS (2021), Republic of Korea.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lee, J.Y., Hur, M.G., Kong, Y.B. et al. Medical radioisotope 89Zr production with RFT-30 cyclotron. J Radioanal Nucl Chem 330, 455–460 (2021). https://doi.org/10.1007/s10967-021-07884-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-021-07884-9